[12] Autoimmune hepatitis type 3 [13,14] is characterized by autoantibodies ... complete cirrhosis and absent inflammatory activity, treatment does not appear to be beneficial.

Hepatitis is a disease that causes inflammation of the liver. It can be caused by one of five contagious viruses. It can also ...

The objectives of this review are to highlight the improvements that have been made in the current treatment of autoimmune hepatitis and to indicate the progress toward new therapies that justify ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

If you’ve recently received a hepatitis C diagnosis, there are several ways you can contribute to the success of your treatment. For example, you can stay on top of your health, communicate with ...

The World Health Organization (WHO) has issued its first guidance for the treatment of hepatitis C, a chronic infection that affects an estimated 130 million to 150 million people and results in ...

While this type of transmission poses a lower ... get a blood test as soon as possible. The hepatitis C virus is treatable, and early treatment leads to a better health outcome.

Hepatitis E, a potentially serious viral liver ... vaccine's effectiveness on other populations and in regions where the type of virus circulating is different from China, as well as the ...

Major investors are betting that a Durham company has a potential cure for hepatitis B. STORY HIGHLIGHTS Tune Therapeutics raised $175 million for disease treatment development. The funding ...

Chronic hepatitis B (CHB) remains a significant global ... Patients were divided into treatment-naïve (TN, n = 123) and treatment-experienced (TE, n = 71) groups. The TN group was further ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

disproving a long-standing theory and opening a promising new approach to developing treatments for autoimmune conditions. The research, published in the journal Immunity, focuses on hepatitis C ...